Germany Diabetes Care Devices Market Analysis & Forecasts to 2015

Product Code GDA00615
Publication Date April 2009
Publisher GlobalData
Product Type Report
Pages 128
ISBN Number not applicable
Change currency
PDF £2,215.00 €2,667 $3,502 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Germany Diabetes Care Devices Market Analysis & Forecasts to 2015

This report is an essential source for in-depth information and data relating to the Germany diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Germany.

Scope

  • The report provides Diabetes care devices market information broken down into detailed categories and segments in Germany.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in Germany.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 Diabetic Care Devices
    • 3.2 Glucose Monitoring Devices
      • 3.2.1 Blood Glucose Meters
      • 3.2.2 Blood Glucose Strips
    • 3.3 Insulin Delivery
      • 3.3.1 Insulin Pens
      • 3.3.2 Insulin Syringes
      • 3.3.3 Insulin Pumps
      • 3.3.4 Traditional Insulin Pump Accessories
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Sector
    • 4.2 Healthcare Expenditure
    • 4.3 Healthcare Infrastructure
      • 4.3.1 Healthcare Personnel Data
      • 4.3.2 Healthcare Facilities Data
    • 4.4 Healthcare Policy
  • 5 Regulation System
    • 5.1 Regulation System
    • 5.2 Medical Equipment Approval Process
      • 5.2.1 Classification of Medical Devices
    • 5.3 Conformity Assessment Process
      • 5.3.1 Class I devices
      • 5.3.2 Class IIa devices
      • 5.3.3 Class IIb devices
      • 5.3.4 Class III devices
    • 5.4 Post Market Surveillance
  • 6 Pricing and Reimbursement
    • 6.1 SHI
      • 6.1.1 Private Health Insurance
      • 6.1.2 Diagnosis Related Groups (DRG)
  • 7 Distribution Structure
  • 8 Diabetes Care Devices In Germany
    • 8.1 A Look In To the Chronic Disease
      • 8.1.1 Type1 and Type2 Diabetes
      • 8.1.2 Diabetes Accentuating Cardiovascular Disease
      • 8.1.3 Diabetes Prevalence
    • 8.2 Diabetes Care Devices, Germany, Overall Revenue ($ m), 2000-2015
    • 8.3 Diabetes Care Devices, Germany, Category Volume (Units), 2000-2015
    • 8.4 Diabetes Care Devices, Germany, Cross Category Analysis, 2000-2015
    • 8.5 German Economic Recession: Impact on the Diabetes Care Devices Market
    • 8.6 Market Dynamics
      • 8.6.1 Market Drivers
      • 8.6.2 Market Restraints
    • 8.7 Diabetes Care Devices, Germany, Company Share (2007-2008)
    • 8.8 Future Outlook
  • 9 Glucose Monitoring In Germany
    • 9.1 Overview
    • 9.2 Glucose Monitoring Overall Revenue (2000-2015)
      • 9.2.1 Blood Glucose Meters Overall Revenue (2000-2015)
    • 9.3 Glucose Monitoring Overall Volume (2000-2015)
      • 9.3.1 Blood Glucose Meters Overall Volume (2000-2015)
    • 9.4 Glucose Monitoring Average Price (2000-2015)
    • 9.5 Glucose Monitoring Market Dynamics
      • 9.5.1 Market Drivers
      • 9.5.2 Market Restraints
    • 9.6 Glucose Monitoring Distribution Share (2007-2008)
    • 9.7 Glucose Monitoring, Germany, Company Share (2007-2008)
  • 10 Insulin Delivery In Germany
    • 10.1 Overview
    • 10.2 Insulin Delivery Overall Revenue (2000-2015)
      • 10.2.1 Insulin Pens Overall Revenue (2000-2015)
    • 10.3 Insulin Delivery Overall Volume (2000-2015)
      • 10.3.1 Insulin Pens Overall Volume (2000-2015)
    • 10.4 Insulin Delivery Average Price (2000-2015)
    • 10.5 Insulin Delivery Market Dynamics
      • 10.5.1 Market Drivers
      • 10.5.2 Market Restraints
    • 10.6 Insulin Delivery Devices Distribution Share (2007-2008)
    • 10.7 Insulin Delivery, Germany, Company Share (2007-2008)
  • 11 Overview of Key Companies in Germany Diabetes Care Devices Market
    • 11.1 F. Hoffmann-La Roche Ltd
      • 11.1.1 Company Overview
      • 11.1.2 Value Chain Analysis
      • 11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products
    • 11.2 Medtronic, Inc
      • 11.2.1 Company Overview
      • 11.2.2 Value Chain Analysis
      • 11.2.3 Medtronic, Inc. Pipeline Products
    • 11.3 LifeScan, Inc
      • 11.3.1 Company Overview
      • 11.3.2 LifeScan, Inc. Pipeline Products
    • 11.4 Abbott Laboratories
      • 11.4.1 Company Overview
      • 11.4.2 Value Chain Analysis
      • 11.4.3 Abbott Laboratories Pipeline Products
    • 11.5 Novo Nordisk A/S
      • 11.5.1 Company Overview
      • 11.5.2 Novo Nordisk A/S Pipeline Products
    • 11.6 Becton, Dickinson and Company
      • 11.6.1 Company Overview
      • 11.6.2 Value Chain Analysis
    • 11.7 Eli Lilly and Company
      • 11.7.1 Company Overview
      • 11.7.2 Value Chain Analysis
      • 11.7.3 Eli Lilly and Company Pipeline Products
    • 11.8 Bayer HealthCare AG
      • 11.8.1 Company Overview
      • 11.8.2 Value Chain Analysis
      • 11.8.3 Bayer HealthCare AG Pipeline Products
    • 11.9 ARKRAY, Inc
      • 11.9.1 Company Overview
      • 11.9.2 ARKRAY, Inc. Pipeline Products
    • 11.10 Terumo Corporation
      • 11.10.1 Company Overview
      • 11.10.2 Value Chain Analysis
    • 11.11 Animas Corporation
      • 11.11.1 Company Overview
    • 11.12 Sanofi-Aventis
      • 11.12.1 Company Overview
    • 11.13 Smiths Medical
      • 11.13.1 Company Overview
      • 11.13.2 Value Chain Analysis
    • 11.14 EKF-diagnostic GmbH
      • 11.14.1 Company Overview
  • 12 Appendix
    • 12.1 GlobalData Research Methodology
    • 12.2 Coverage
    • 12.3 Secondary Research
    • 12.4 Primary Research
    • 12.5 Models
    • 12.6 Forecasts
    • 12.7 Expert Panel Validation
    • 12.8 Currency Conversion
    • 12.9 Contact Us
    • 12.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Healthcare Expenditure in Germany, (€m), 2000 - 2006
    • Table 2: Healthcare Personnel by Region in Germany, 2007
    • Table 3: Doctors by Specialty in Germany, 2000-2004
    • Table 4: Hospitals by Region in Germany, 2004
    • Table 5: Hospitals and Beds by Region in Germany, 2007
    • Table 6: Rehabilitation Centers by Region in Germany, 2004
    • Table 7: Rehabilitation Center Beds by Region in Germany, 2004
    • Table 8: Discharges by Diagnosis in Germany, 2004
    • Table 9: Diabetes Prevalence Rates, 2007
    • Table 10: Diabetes Care Devices, Germany, Overall Revenue ($ m), Historic, 2000-2008
    • Table 11: Diabetes Care Devices, Germany, Overall Revenue ($ m), Forecast, 2008-2015
    • Table 12: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2000-2008
    • Table 13: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2008-2015
    • Table 14: Diabetes Care Devices, Germany, Cross-Category Analysis, 2000-2015
    • Table 15: Diabetes Care Devices, Germany, Company Share by Revenue ($ m), 2007-2008
    • Table 16: Glucose Monitoring, Germany, Revenue ($ m) by Segment, Historic, 2000-2008
    • Table 17: Glucose Monitoring, Germany, Revenue ($ m) by Segment, Forecast, 2008-2015
    • Table 18: Blood Glucose Meters, Germany, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
    • Table 19: Blood Glucose Meters, Germany, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
    • Table 20: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2000-2008
    • Table 21: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 22: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 23: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 24: Glucose Monitoring, Germany, Average Price ($), Historic, 2000-2008
    • Table 25: Glucose Monitoring, Germany, Average Price ($), Forecast, 2008-2015
    • Table 26: Glucose Monitoring, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 27: Glucose Monitoring, Germany, Company Share by Revenue ($ m), 2007-2008
    • Table 28: Insulin Delivery, Germany, Revenue ($ m) by Segment, Historic, 2000-2008
    • Table 29: Insulin Delivery, Germany, Revenue ($ m) by Segment, Forecast, 2008-2015
    • Table 30: Insulin Pens, Germany, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
    • Table 31: Insulin Pens, Germany, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
    • Table 32: Insulin Delivery, Germany, Volume (Units) by Segment, Historic, 2000-2008
    • Table 33: Insulin Delivery, Germany, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 34: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 35: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 36: Insulin Delivery, Germany, Average Price ($), Historic, 2000-2008
    • Table 37: Insulin Delivery, Germany, Average Price ($), Forecast, 2008-2015
    • Table 38: Insulin Delivery, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 39: Insulin Delivery, Germany, Company Share by Revenue ($ mn), 2007-2008
    • Table 40: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
    • Table 41: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
    • Table 42: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area
    • Table 43: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 44: Medtronic, Inc. Pipeline Products By Development Stage
    • Table 45: Medtronic, Inc. Pipeline Products By Therapy Area
    • Table 46: Medtronic, Inc. Pipeline Products By Clinical Trials
    • Table 47: Medtronic, Inc. Pipeline Products By News Summary
    • Table 48: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 49: LifeScan, Inc. Pipeline Products by Development Stage
    • Table 50: LifeScan, Inc. Pipeline Products by Therapy Area
    • Table 51: LifeScan, Inc. Pipeline Products by Clinical Trials
    • Table 52: LifeScan, Inc. Pipeline Products by News Summary
    • Table 53: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 54: Abbott Laboratories Pipeline Products by Development Stage
    • Table 55: Abbott Laboratories Pipeline Products by Therapy Area
    • Table 56: Abbott Laboratories Pipeline Products by Clinical Trials
    • Table 57: Abbott Laboratories Pipeline Products by News Summary
    • Table 58: Novo Nordisk A/S Pipeline Products by Equipment Type
    • Table 59: Novo Nordisk A/S Pipeline Products By Development Stage
    • Table 60: Novo Nordisk A/S Pipeline Products By Therapy Area
    • Table 61: Novo Nordisk A/S Pipeline Products By Clinical Trials
    • Table 62: Eli Lilly and Company Pipeline Products by Equipment Type
    • Table 63: Eli Lilly and Company Pipeline Products by Development Stage
    • Table 64: Eli Lilly and Company Pipeline Products by Therapy Area
    • Table 65: Eli Lilly and Company Pipeline Products by Clinical Trials
    • Table 66: Eli Lilly and Company Pipeline Products by News Summary
    • Table 67: Bayer HealthCare AG Pipeline Products by Equipment Type
    • Table 68: Bayer HealthCare AG Pipeline Products by Development Stage
    • Table 69: Bayer HealthCare AG Pipeline Products by Therapy Area
    • Table 70: Bayer HealthCare AG Pipeline Products by News Summary
    • Table 71: ARKRAY, Inc. Pipeline Products by Equipment Type
    • Table 72: ARKRAY, Inc. Pipeline Products by Development Stage
    • Table 73: ARKRAY, Inc. Pipeline Products by Clinical Trials
    • Table 74: ARKRAY, Inc. Pipeline Products by News Summary
    • Table 75: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Healthcare Expenditure Sources in Germany, 2006
    • Figure 2: Healthcare Financing Framework in Germany, 2007
    • Figure 3: Flowchart for Classification of Non-invasive Devices in Germany, 2007
    • Figure 4: Flowchart for Classification of Invasive Devices in Germany, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in Germany, 2007
    • Figure 6: Classification of Invasive Devices in Germany, 2007
    • Figure 7: Classification of Invasive Devices in Germany, 2007
    • Figure 8: Flowchart for Classification of Active Devices in Germany, 2007
    • Figure 9: Flowchart for Classification of Active Devices in Germany, 2007
    • Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007
    • Figure 11: Conformity Assessment of Class-I Medical Devices in Germany, 2007
    • Figure 12: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007
    • Figure 13: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007
    • Figure 14: Conformity Assessment of Class-III Medical Devices in Germany, 2007
    • Figure 15: Diabetes Care Devices, Germany, Overall Revenue ($ m), Historic, 2000-2008
    • Figure 16: Diabetes Care Devices, Germany, Overall Revenue ($ m), Forecast, 2008-2015
    • Figure 17: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2000-2008
    • Figure 18: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2008-2015
    • Figure 19: Diabetes Care Devices, Germany, Cross-Category Analysis, 2000-2015
    • Figure 20: Diabetes Care Devices, Germany, Company Share (%), 2008
    • Figure 21: Glucose Monitoring, Germany, Revenue ($ m) by Segment, Historic, 2000-2008
    • Figure 22: Glucose Monitoring, Germany, Revenue ($ m) by Segment, Forecast, 2008-2015
    • Figure 23: Blood Glucose Meters, Germany, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
    • Figure 24: Blood Glucose Meters, Germany, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
    • Figure 25: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 26: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 27: Glucose Monitoring, Germany, Company Share (%), 2008
    • Figure 28: Insulin Delivery, Germany, Revenue ($ m) by Segment, Historic, 2000-2008
    • Figure 29: Insulin Delivery, Germany, Revenue ($ m) by Segment, Forecast, 2008-2015
    • Figure 30: Insulin Pens, Germany, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
    • Figure 31: Insulin Pens, Germany, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
    • Figure 32: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 33: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 34: Insulin Delivery, Germany, Company Share (%), 2008
    • Figure 35: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 36: Medtronic, Inc. Value Chain Analysis
    • Figure 37: Abbott Laboratories Value Chain Analysis
    • Figure 38: Becton, Dickinson and Company Value Chain Analysis
    • Figure 39: Eli Lilly and Company Value Chain Analysis
    • Figure 40: Bayer HealthCare AG Value Chain Analysis
    • Figure 41: Terumo Corporation Value Chain Analysis
    • Figure 42: Smiths Medical Value Chain Analysis
    • Figure 43: GlobalData Methodology